Search research articles
Contact Us
Filters
Showing results (41-50 of 97) with videos related to
Page
of 10
Sort By:
Diabetes, Obesity & Metabolism
|
January 6, 2025
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia
|
May 22, 2023
Correction to: The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia
|
November 21, 2022
The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia
|
October 7, 2017
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Suzy V Hope, Bridget A Knight, Beverley M Shields, et al.
Diabetologia
|
June 5, 2023
HbA
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Nature Medicine
|
December 8, 2022
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
Beverley M Shields, Catherine D Angwin, Maggie H Shepherd, et al.
The Lancet. Child & Adolescent Health
|
February 18, 2024
Long-term outcomes after severe childhood malnutrition in adolescents in Malawi (LOSCM): a prospective observational cohort study
Amir Kirolos, Philliness P Harawa, Takondwa Chimowa, et al.
Diabetologia
|
October 15, 2013
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
Richard A Oram, Angus G Jones, Rachel E J Besser, et al.
Diabetes Care
|
October 7, 2022
Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation
Russell J Eason, Nicholas J Thomas, Anita V Hill, et al.
BMJ Open Diabetes Research & Care
|
May 26, 2020
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
Andrew P McGovern, Michael Hogg, Beverley M Shields, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 97) with videos related to
Sort By:
Page
of 10
Diabetes, Obesity & Metabolism
|
January 6, 2025
Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): A population-based cohort study
Rhian Hopkins, Katherine G Young, Nicholas J Thomas, et al.
Diabetologia
|
May 22, 2023
Correction to: The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia
|
November 21, 2022
The impact of population-level HbA<sub>1c</sub> screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Diabetologia
|
October 7, 2017
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Suzy V Hope, Bridget A Knight, Beverley M Shields, et al.
Diabetologia
|
June 5, 2023
HbA
Katherine G Young, Andrew P McGovern, Inês Barroso, et al.
Nature Medicine
|
December 8, 2022
Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study
Beverley M Shields, Catherine D Angwin, Maggie H Shepherd, et al.
The Lancet. Child & Adolescent Health
|
February 18, 2024
Long-term outcomes after severe childhood malnutrition in adolescents in Malawi (LOSCM): a prospective observational cohort study
Amir Kirolos, Philliness P Harawa, Takondwa Chimowa, et al.
Diabetologia
|
October 15, 2013
The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
Richard A Oram, Angus G Jones, Rachel E J Besser, et al.
Diabetes Care
|
October 7, 2022
Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation
Russell J Eason, Nicholas J Thomas, Anita V Hill, et al.
BMJ Open Diabetes Research & Care
|
May 26, 2020
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation
Andrew P McGovern, Michael Hogg, Beverley M Shields, et al.
Page
of 10